PV Bulletin

Updated support package for ICH M8: Electronic Common Technical Document (eCTD)

The ICH has released an updated support package for the M8 eCTD guideline, providing the latest technical specifications and tools for electronic regulatory submissions.

Primary source: International Council for Harmonisation (ICH)

PV Impact Brief

Urgency: HighConfidence: high

What changed

New technical specifications and updated validation criteria for compiling safety-related submissions such as PBRERs, RMPs, and PSURs have been introduced in the M8 eCTD support package.

Why it matters

Implementation of the latest eCTD specifications is crucial to prevent technical validation failures that could lead to delays in submission acceptance and maintain the integrity of safety data transmission to regulators.

Action needed

Regulatory operations teams must ensure compliance by compiling safety submissions in accordance with the new eCTD technical specifications and avoiding outdated support materials.

Relevant for
Regulatory Intelligence LeadQPPV
Processes impacted
Country Compliance
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Policy change details

Document type
Technical Support Package
Policy status
revised
Publication date
2026-07-30
Policy change
The ICH has released an updated support package for the M8 eCTD guideline, providing the latest technical specifications and tools for electronic regulatory submissions. This update is part of the ongoing maintenance of the eCTD standard to ensure it remains functional and aligned with regional regulatory requirements. The package includes updated validation criteria and technical instructions for compiling and transmitting dossiers.

Key changes

Updated eCTD validation criteria and technical support files. Refinements to the electronic structure requirements for regulatory dossiers, including those containing safety reporting sections.

Affected workflows

Country Compliance

Responsible groups

Regulatory OperationsPharmacovigilance ReportingIT/Safety Systems

PV impact

PV reporting and regulatory operations teams must ensure that safety submissions such as PBRERs, RMPs, and PSURs are compiled using the latest eCTD technical specifications. Use of outdated support materials can lead to technical validation failures and delays in submission acceptance. This update is critical for maintaining the integrity of electronic safety data transmission to regulators.

View regulator source

Source document details

Extracted documents

Evidence and confidence

Confidence: highSource updated: Jul 30, 2026

Full briefing

Practical implication

Regulatory operations teams must ensure compliance by compiling safety submissions in accordance with the new eCTD technical specifications and avoiding outdated support materials.

The ICH has published an updated support package for the M8 eCTD guideline, which includes new technical specifications, validation criteria, and instructions necessary for compiling and transmitting electronic regulatory dossiers. The update emphasizes the importance of using current support materials to avoid validation failures in safety submissions.

What changed: New technical specifications and updated validation criteria for compiling safety-related submissions such as PBRERs, RMPs, and PSURs have been introduced in the M8 eCTD support package.

Why it matters: Implementation of the latest eCTD specifications is crucial to prevent technical validation failures that could lead to delays in submission acceptance and maintain the integrity of safety data transmission to regulators.

Practical implication: Regulatory operations teams must ensure compliance by compiling safety submissions in accordance with the new eCTD technical specifications and avoiding outdated support materials.

View original source

Published from the Firecrawl policy change extraction pipeline.

Related updates for your role

publicFDA · United States · Updated Aug 17, 2026

Revised FDA Guidance on ANDA and 505(b)(2) Application Submission

Urgency: High

Implement a gap analysis for 505(b)(2) applications to identify safety data needs and adjust safety monitoring systems as necessary to accommodate new product characteristics.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Draft Guidance
Read impact briefarrow_forward
publicMedicines and Healthcare products Regulatory Agency (MHRA) · United Kingdom · Updated Aug 18, 2026

UK Position Paper on Microbiome-Based Medicinal Products (MBMPs)

Urgency: High

MAHs and sponsors must enhance their pharmacovigilance systems to monitor microbiome-specific safety issues, comply with established safety standards, and address concerns related to antimicrobial resistance.

Signal ManagementCountry ComplianceRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead, QPPV
verifiedRegulatory action: Position Paper
Read impact briefarrow_forward
publicU.S. Food and Drug Administration · United States · Updated Aug 18, 2026

Regulatory Framework for Generative AI-Enabled Medical Devices

Urgency: High

Stakeholders, including manufacturers and clinicians, must review and potentially revise their post-market vigilance and safety monitoring protocols in response to the FDA's proposed regulatory approaches for generative AI devices.

Signal ManagementICSRRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead, QPPV
verifiedRegulatory action: Notice
Read impact briefarrow_forward
publicMHRA · United Kingdom · Updated Aug 18, 2026

MHRA Clarifies Regulatory Pathways for Microbiome-Based Medicinal Products

Urgency: High

Developers of MBMPs must align their safety assessment protocols with the MHRA's expectations and are encouraged to engage with the MHRA early to establish appropriate regulatory strategies.

Literature SurveillanceCountry ComplianceRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Notice / Position Paper
Read impact briefarrow_forward